Company Email Format Management

NeoPhore Ltd

Biotechnology Research United Kingdom 22 employees

Employees: 22
Contacts: 2
Emails: 2
Phones: 1

neophore.com LinkedIn Crunchbase

NeoPhore Ltd Overview

Headquarters: United Kingdom
Phone Number: Available in AeroLeads
Website: neophore.com
Industry: Biotechnology Research
Employees: 22
Founded: 2017
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology Drug Discovery Small Molecule Therapeutics Oncology Immuno-oncology Cancer Genetics Translational Medicine

About NeoPhore Ltd

NeoPhore, UK is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system. Generation of cancer neoantigens in tumours can be exploited by the patients’ immune system to overcome natural defence mechanisms in cancer. The Company’s approach targets the DNA mismatch repair (MMR) pathway, which has been proven to promote neoantigen creation and subsequent immunity against numerous cancers. Using these insights, NeoPhore aims to generate next-generation immuno-oncology therapeutics to improve clinical outcomes for cancer patients. NeoPhore was spun-out of the University of Turin and PhoreMost Ltd by the CRT Pioneer Fund.

NeoPhore Ltd Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

NeoPhore Ltd Org Chart

Sample employees and titles

Name	Title	Location	Contact
Pietro Puglisi	Partner at Claris Ventures		View
Julian Blagg		London, England, United Kingdom	Email
Michael Shih	Chief Executive Officer @ Neophore Ltd		View
John Haurum		Copenhagen, Capital Region of Denmark, Denmark	Email Phone